JPRN-UMIN000008138已完成未知
Efficacy and safety of silodosin on lower urinary tract symptoms (LUTS) in patients with Parkinson's disease - Efficacy and safety of silodosin on lower urinary tract symptoms (LUTS) in patients with Parkinson's disease
Juntendo University School of Medicine0 个研究点目标入组 100 人开始时间: 2012年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •Patients who 1) is taking other alpha 1-blockers (Harnal, Flivas), or who cannot do washout taking these drugs 2) had taken anti-androgens or 5 alpha-reductase inhibitors 6 months before the informed consent 3) cannot quit concomitant medications. 4) Cannot record subjective symptoms because of dementia etc. (23>=MMSE) 5) have had surgical treatment such as TURP, thermo thrapy, HoLEP etc. 6) primary physician judged as inadequate to entry in this study
研究者
相似试验
尚未招募
不适用
The clinical effect of Silodosin for lower urinary tract symptoms after permanent prostate brachytherapyProstate cancerJPRN-UMIN000004146Kobe University Hospital60
已完成
4 期
Oral Silodosin on Lower Urinary Tract Symptoms Due to Double-J stent: A Prospectively Randomized Studyurinary symptoms assosciated with indwelling double-J ureteral stentsRenal and Urogenital - Other renal and urogenital disordersACTRN12611000569909Chung Jing Wang45
进行中（未招募）
1 期
A clinical study, which evaluates the effectiveness and the safety of a new medication for prostatic hyperplasia, silodosin, when administered under normal conditions of use in a wide European population.EUCTR2011-000045-20-ESRECORDATI S.p.A
进行中（未招募）
1 期
Effectiveness and safety of silodosin in the treatment of patients with benign prostatic hyperplasia.Benign prostatic hyperplasia.EUCTR2011-000045-20-RORECORDATI S.p.A
进行中（未招募）
不适用
Effectiveness and safety of silodosin in the treatment of LUTS in patients with benign prostatic hyperplasia: a European phase IV clinical study (the Silodosin in Real-life Evaluation study) - SIREBenign prostatic hyperplasia.MedDRA version: 13.1Level: PTClassification code 10004446Term: Benign prostatic hyperplasiaSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2011-000045-20-HURECORDATI S.p.A1,000